A videotaped expert commentary by Dr. Johann de Bono on the Medscape Oncology web site (with transcript) discusses four therapies (three now approved in the USA) that have recently demonstrated a survival benefit in the treatment of metastatic, castration-resistant prostate cancer.
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment Tagged: | abiraterone acetate, cabazitaxel, radium-223, sipuleucel-T
Search for new and
ongoing trials on the
CTAG PCa web site
